Antiallergic activity of tylogenin (cas 135247-46-0), a novel steroidal compound from tylophora sylvatica

Add time:08/09/2019    Source:sciencedirect.com

Tylogenin, a steroidal aglycone generated by acid hydrolysis from two seasonal glycosides occurring in Tylophora sylvatica, inhibits IgE-induced basophil mediator release for allergic reactions. In the rabbit basophil-dependent serotonin release (BDSR) assay system, the inhibitory activity of tylogenin (geom mean IC50 = 39 μM) was significantly (P<0.05) greater than that of its parent glycosides, tylophoroside (geom mean IC50 253 μM) and acetyltylophoroside (geom mean IC50 331 μM), and that of dexamethasone (geom mean IC50 = 912 μM). The activity of tylogenin was found to increase with the incubation time. In the human leukocyte-dependent histamine release (LDHR) test model, the glycosides had only a minimal activity. In contrast, tylogenin, with a geom mean IC50 = 49 μM, exerted a significantly (P<0.05) greater potency than dexamethasone (IC50 = 257 μM). These results suggest that tylogenin could represent a new class of antiallergic agents.

We also recommend Trading Suppliers and Manufacturers of tylogenin (cas 135247-46-0). Pls Click Website Link as below: cas 135247-46-0 suppliers

Prev:NIP-121 and cromakalim, potassium channel openers, preferentially suppress prostanoid-induced contraction of the guinea-pig isolated trachea
Next:Validated rapid resolution LC-ESI–MS/MS method for simultaneous determination of five pulchinenosides from Pulsatilla chinensis (Bunge) Regel in rat plasma: Application to pharmacokinetics and bioavailability studies)